UroGen Pharma Ltd. | ||||
NGM : URGN || Location: United States | ||||
$14.53+0.16 (+1.11%) |
0.22 M | 14.11 - 14.85 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 4.186 M |
March 15, 2024 | 4.252 M |
Feb. 29, 2024 | 3.935 M |
Feb. 15, 2024 | 4.011 M |
Jan. 31, 2024 | 3.258 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.69 | -0.72 | -3.81% |
09/30/2023 | -0.86 | -0.68 | 21.20% |
06/30/2023 | -1.16 | -1.03 | 11.11% |
03/31/2023 | -1.36 | -1.30 | 4.17% |
12/31/2022 | -1.09 | -1.22 | -11.44% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 34.122M | Shares Float | 24.372M |
Short Float | 4.186M | Market Cap | 490.33M |
Institution ownership | 70.49% | Insider ownership | 11.351% |
Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
Trailing EPS | -3.55 | Forward EPS | -2.36 |